IL-33 deficiency in these cells impairs their suppressive capacity by inducing epigenetic reprogramming that increases IFN-γ expression in an NF-κB and T-bet-dependent manner, which alters the tumor immune response (82) Figure 3D. The gene discussed is IFNG; the disease is neoplasm.